Pharmafile Logo
Pharmafocus logo
Advanced Search
moderna_norwood_plant

Moderna and Pfizer COVID-19 vaccine protection declines over time

September 16, 2021
Business Services COVID-19, FDA, Moderna, Pfizer, comirnaty

Data presented by Pfizer and Moderna ahead of the FDA’s vaccine advisory committee meeting on Friday suggest that protection from …

News

Researchers develop AI algorithm to diagnose deep vein thrombosis

September 16, 2021
Medical Communications, Research and Development

Researchers from the University of Oxford, Imperial College, and the University of Sheffield have developed a machine learning algorithm with …

News

Menstrual changes after COVID jab must be investigated, says leading immunologist

September 16, 2021
Medical Communications

Changes to periods and unexpected vaginal bleeding has been reported by 30,000 women to UK regulators, and now leading immunologist …

News

Sanofi complete acquisition of mRNA company Translate Bio

September 15, 2021
Research and Development 2021, 3.2 billion, COVID-19, Sanofi, Translate Bio, acquisition, mrna, vaccines

French pharma giants Sanofi continues its run of acquisitions in 2021 by completing the deal for Translate Bio, a Massachusetts-based …

News

COVID deaths among fully vaccinated rare, ONS data finds

September 15, 2021
Medical Communications, Research and Development

New figures from the Office for National Statistics (ONS) show that fully vaccinated people are far less likely to die …

News

Sajid Javid: Valneva COVID vaccine would not have been approved by MHRA

September 15, 2021
Manufacturing and Production, Medical Communications, Research and Development

On Monday the UK cancelled a deal with French vaccine maker Valneva worth up to €1.4 billion, and Health Secretary …

News
nhs_sign

NHS in Scotland makes rheumatoid arthritis drug available

September 14, 2021
Manufacturing and Production Galapagos UK, NHS, Scotland, filgotinib, rheumatoid arthritis

The Scottish Medicines Consortium (SMC) have recommended the use of Galapagos UK’s JYSELECA® (filgotinib) for eligible patients with severe active …

News

Israeli survey finds 1 in 10 children have long COVID

September 14, 2021
Medical Communications, Research and Development

An Israeli Health Ministry survey has found that one in ten children have lingering COVID-19 symptoms after contracting and recovering …

News

J&J publish promising Ebola vaccine data

September 14, 2021
Research and Development

Johnson & Johnson have released promising data regarding their Ebola vaccine regimen, as it demonstrates antibody immune responses in adults …

News

NHS launches new blood test to detect over 50 types of cancer early

September 13, 2021
Sales and Marketing

A world-first trial of a new cancer test began today as the NHS launched its Galleri trial, which seeks to …

News
dw-anzcxqaqavhl

BioNTech seek approval for COVID-19 vaccine in children aged 5-11

September 13, 2021
Sales and Marketing COVID-19, FDA, Vaccine, children

Children between 5 and 11 years old are to be targeted by BioNTech as the company seeks approval for younger …

News
valneva-05

Valneva COVID-19 vaccine deal pulled by UK government

September 13, 2021
Research and Development, Sales and Marketing Boris Johnson, Scotland, UK government, Vaccine, Valneva, booster, covid19

Boris Johnson and the UK government have terminated its deal with specialist vaccine company Valneva after it was alleged the …

News

NICE recommends Pfizer’s Xeljanz for juvenile idiopathic arthritis

September 10, 2021
Medical Communications

NICE has published final draft guidance recommending the use of Pfizer’s Xeljanz (tofacitinib) as an option for treating active polyarticular …

News

Pfizer and AstraZeneca approved as booster COVID vaccines

September 10, 2021
Medical Communications

The MHRA has approved the use of Pfizer and AstraZeneca’s COVID-19 vaccines for the planned booster programme this winter. However, …

News
nhs_old_hospital_1

NHS lung cancer patients to receive Amgen’s tumour-stopping drug

September 10, 2021
Medical Communications, Research and Development

NHS patients will be the first in Europe to receive a new drug that can prevent lung cancer tumour growth, …

News

FDA grants Fast Track Designation for Vor Biopharma’s AML drug

September 10, 2021
Medical Communications, Research and Development

Vor Biopharma has announced that the FDA has granted their acute myeloid leukemia (AML) engineered hematopoietic stem cell therapy (eHSC), …

News

Hope for non-cystic fibrosis bronchiectasis patients following positive Phase III results

September 9, 2021

Pharmaceutical company Zambon has announced positive results from the Phase III PROMIS-I study, which examined the use of colistimethate sodium …

News

AstraZeneca’s asthma drug reveals success in Phase III trials

September 9, 2021

Avillion have announced the success of the MANDALA and DENALI Phase III trials of AstraZeneca’s PT027 (albuterol/budesonide), which revealed the …

News

Novavax begins clinical trial for combined influenza and COVID vaccine

September 9, 2021

US vaccine developer Novavax has announced the initiation of an early stage clinical trial investigating its combined influenza and COVID-19 …

News

Compulsory COVID and flu jabs being considered for England health staff

September 9, 2021

Plans to make COVID-19 and flu vaccinations compulsory for frontline NHS staff in England are currently being discussed by the …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025